These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prevention and reversal of hepatic steatosis with a high-protein diet in mice. Garcia-Caraballo SC, Comhair TM, Verheyen F, Gaemers I, Schaap FG, Houten SM, Hakvoort TB, Dejong CH, Lamers WH, Koehler SE. Biochim Biophys Acta; 2013 May; 1832(5):685-95. PubMed ID: 23410526 [Abstract] [Full Text] [Related]
3. A high-protein diet is anti-steatotic and has no pro-inflammatory side effects in dyslipidaemic APOE2 knock-in mice. Garcia Caraballo SC, Comhair TM, Dejong CH, Lamers WH, Köhler SE. Br J Nutr; 2014 Oct 28; 112(8):1251-65. PubMed ID: 25160499 [Abstract] [Full Text] [Related]
4. The odd-carbon medium-chain fatty triglyceride triheptanoin does not reduce hepatic steatosis. Comhair TM, Garcia Caraballo SC, Dejong CH, Lamers WH, Koehler SE. Clin Nutr; 2017 Feb 28; 36(1):229-237. PubMed ID: 26778339 [Abstract] [Full Text] [Related]
5. Spironolactone improves glucose and lipid metabolism by ameliorating hepatic steatosis and inflammation and suppressing enhanced gluconeogenesis induced by high-fat and high-fructose diet. Wada T, Kenmochi H, Miyashita Y, Sasaki M, Ojima M, Sasahara M, Koya D, Tsuneki H, Sasaoka T. Endocrinology; 2010 May 28; 151(5):2040-9. PubMed ID: 20211973 [Abstract] [Full Text] [Related]
6. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice. Malloy VL, Perrone CE, Mattocks DA, Ables GP, Caliendo NS, Orentreich DS, Orentreich N. Metabolism; 2013 Nov 28; 62(11):1651-61. PubMed ID: 23928105 [Abstract] [Full Text] [Related]
8. Dietary treatment of fatty liver: High dietary protein content has an antisteatotic and antiobesogenic effect in mice. Garcia Caraballo SC, Comhair TM, Dejong CHC, Lamers WH, Koehler SE. Biochim Biophys Acta Mol Basis Dis; 2017 Jul 28; 1863(7):1789-1804. PubMed ID: 28457799 [Abstract] [Full Text] [Related]
9. Dietary β-conglycinin prevents fatty liver induced by a high-fat diet by a decrease in peroxisome proliferator-activated receptor γ2 protein. Yamazaki T, Kishimoto K, Miura S, Ezaki O. J Nutr Biochem; 2012 Feb 28; 23(2):123-32. PubMed ID: 21447441 [Abstract] [Full Text] [Related]
10. Branched-chain amino acids alleviate hepatic steatosis and liver injury in choline-deficient high-fat diet induced NASH mice. Honda T, Ishigami M, Luo F, Lingyun M, Ishizu Y, Kuzuya T, Hayashi K, Nakano I, Ishikawa T, Feng GG, Katano Y, Kohama T, Kitaura Y, Shimomura Y, Goto H, Hirooka Y. Metabolism; 2017 Apr 28; 69():177-187. PubMed ID: 28285648 [Abstract] [Full Text] [Related]
11. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet. Kang JH, Goto T, Han IS, Kawada T, Kim YM, Yu R. Obesity (Silver Spring); 2010 Apr 28; 18(4):780-7. PubMed ID: 19798065 [Abstract] [Full Text] [Related]
12. Effects of long-term administration of saturated and n-3 fatty acid-rich diets on lipid utilisation and oxidative stress in rat liver and muscle tissues. Feillet-Coudray C, Aoun M, Fouret G, Bonafos B, Ramos J, Casas F, Cristol JP, Coudray C. Br J Nutr; 2013 Nov 28; 110(10):1789-802. PubMed ID: 23656726 [Abstract] [Full Text] [Related]
13. Dietary phosphate restriction induces hepatic lipid accumulation through dysregulation of cholesterol metabolism in mice. Tanaka S, Yamamoto H, Nakahashi O, Kagawa T, Ishiguro M, Masuda M, Kozai M, Ikeda S, Taketani Y, Takeda E. Nutr Res; 2013 Jul 28; 33(7):586-93. PubMed ID: 23827134 [Abstract] [Full Text] [Related]
14. Effects of dietary phosphate on glucose and lipid metabolism. Abuduli M, Ohminami H, Otani T, Kubo H, Ueda H, Kawai Y, Masuda M, Yamanaka-Okumura H, Sakaue H, Yamamoto H, Takeda E, Taketani Y. Am J Physiol Endocrinol Metab; 2016 Apr 01; 310(7):E526-38. PubMed ID: 26786774 [Abstract] [Full Text] [Related]
15. High dietary protein decreases fat deposition induced by high-fat and high-sucrose diet in rats. Chaumontet C, Even PC, Schwarz J, Simonin-Foucault A, Piedcoq J, Fromentin G, Azzout-Marniche D, Tomé D. Br J Nutr; 2015 Oct 28; 114(8):1132-42. PubMed ID: 26285832 [Abstract] [Full Text] [Related]
16. Schizandrin A supplementation improves nonalcoholic fatty liver disease in mice fed a high-fat and high-cholesterol diet. Jeong MJ, Kim SR, Jung UJ. Nutr Res; 2019 Apr 28; 64():64-71. PubMed ID: 30802724 [Abstract] [Full Text] [Related]
17. Isocaloric Diets High in Animal or Plant Protein Reduce Liver Fat and Inflammation in Individuals With Type 2 Diabetes. Markova M, Pivovarova O, Hornemann S, Sucher S, Frahnow T, Wegner K, Machann J, Petzke KJ, Hierholzer J, Lichtinghagen R, Herder C, Carstensen-Kirberg M, Roden M, Rudovich N, Klaus S, Thomann R, Schneeweiss R, Rohn S, Pfeiffer AF. Gastroenterology; 2017 Feb 28; 152(3):571-585.e8. PubMed ID: 27765690 [Abstract] [Full Text] [Related]
18. Effect of dietary monosodium glutamate on trans fat-induced nonalcoholic fatty liver disease. Collison KS, Maqbool Z, Saleh SM, Inglis A, Makhoul NJ, Bakheet R, Al-Johi M, Al-Rabiah R, Zaidi MZ, Al-Mohanna FA. J Lipid Res; 2009 Aug 28; 50(8):1521-37. PubMed ID: 19001666 [Abstract] [Full Text] [Related]
19. Effects of Diets Differing in Composition of 18-C Fatty Acids on Adipose Tissue Thermogenic Gene Expression in Mice Fed High-Fat Diets. Shin S, Ajuwon KM. Nutrients; 2018 Feb 23; 10(2):. PubMed ID: 29473916 [Abstract] [Full Text] [Related]
20. Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease. Ganji SH, Kukes GD, Lambrecht N, Kashyap ML, Kamanna VS. Am J Physiol Gastrointest Liver Physiol; 2014 Feb 15; 306(4):G320-7. PubMed ID: 24356885 [Abstract] [Full Text] [Related] Page: [Next] [New Search]